Management of Severe Gastritis in Pregnancy
For severe gastritis symptoms during pregnancy, initiate a stepwise treatment approach starting with dietary modifications and vitamin B6 (10-25 mg every 8 hours), then escalate to doxylamine-pyridoxine combination therapy, followed by metoclopramide or ondansetron for refractory cases, with intravenous glucocorticoids reserved as last-resort therapy for hyperemesis gravidarum. 1
Initial Assessment and Severity Stratification
First, quantify symptom severity using the Motherisk PUQE scoring system (maximum score 15): mild (≤6), moderate (7-12), or severe (≥13). This helps guide treatment intensity and identifies patients at risk for progression to hyperemesis gravidarum (HG), which affects 0.3-2% of pregnancies and involves dehydration, >5% weight loss, and electrolyte imbalances. 1
Evaluate for signs of dehydration including orthostatic hypotension and decreased skin turgor. Check for electrolyte abnormalities, particularly hypokalemia and metabolic alkalosis. Rule out other causes including hyperthyroidism, molar pregnancy, and multiple gestations. 1
Stepwise Treatment Algorithm
First-Line: Non-Pharmacologic Interventions
Dietary modifications: Implement small, frequent, bland meals (BRAT diet: bananas, rice, applesauce, toast). Emphasize high-protein, low-fat meals. Eliminate spicy, fatty, acidic, and fried foods that trigger symptoms. 1
Ginger supplementation: 250 mg capsules four times daily, as recommended by ACOG. 1
Vitamin B6 (pyridoxine): 10-25 mg every 8 hours as first-line pharmacologic therapy. 1
Second-Line: Combination Antiemetic Therapy
Doxylamine-pyridoxine combination is FDA-approved and ACOG-recommended for persistent symptoms refractory to non-pharmacologic therapy. Available as 10 mg/10 mg or 20 mg/20 mg combinations, this is safe and well-tolerated throughout pregnancy. 1
Critical point: Early intervention at this stage may prevent progression to hyperemesis gravidarum, which carries risks of low birth weight, small for gestational age infants, and premature delivery. 1
Third-Line: H1-Receptor Antagonists
If symptoms persist, add promethazine or dimenhydrinate as safe first-line H1-receptor antagonists. These are considered safe throughout pregnancy. 1
Fourth-Line: Prokinetic and Serotonin Antagonists
Metoclopramide is preferred over promethazine for hospitalized patients due to less drowsiness, dizziness, and dystonia, with similar efficacy. No increased risk of congenital defects has been reported. However, withdraw immediately if extrapyramidal symptoms develop. 1
Ondansetron should be reserved for severe cases requiring hospitalization and used as second-line therapy only. While not associated with increased stillbirth or spontaneous abortion risk, some studies report congenital heart defects when given before 10 weeks gestation. ACOG recommends case-by-case use before 10 weeks. 1
Important caveat: A Cochrane meta-analysis of 25 studies found no significant efficacy difference among metoclopramide, ondansetron, and promethazine, so choice should be based on side effect profile and gestational age. 1
Severe/Refractory Cases: Hyperemesis Gravidarum Management
Hospitalization Criteria
- Dehydration with orthostatic changes
- Weight loss >5% of prepregnancy weight
- Electrolyte abnormalities
- Inability to tolerate oral intake
Inpatient Management
IV hydration and electrolyte replacement is the cornerstone. Add thiamine 100 mg daily for minimum 7 days to prevent Wernicke encephalopathy and refeeding syndrome, then maintain at 50 mg daily until adequate oral intake established. 1
Methylprednisolone as last resort: 16 mg IV every 8 hours for up to 3 days, then taper over 2 weeks to lowest effective dose (maximum 6 weeks duration). This reduces rehospitalization rates but carries slight increased risk of cleft palate when given before 10 weeks gestation—use with extreme caution in first trimester. 1
If weight loss and symptoms persist despite maximal medical therapy, consider enteral or parenteral nutrition. 1
Multidisciplinary Coordination
Severe cases require collaboration between gastroenterology, obstetrics, maternal-fetal medicine, nutrition, and mental health professionals. Anxiety and depression commonly accompany severe symptoms and require concurrent management. 1
Key Pitfalls to Avoid
- Don't delay treatment: Early aggressive management prevents progression to HG with its associated maternal-fetal complications
- Don't withhold ondansetron categorically: While caution is warranted before 10 weeks, severe maternal dehydration and malnutrition pose greater fetal risks than theoretical cardiac defect risk
- Don't forget thiamine: Wernicke encephalopathy is preventable and devastating
- Don't use metoclopramide or phenothiazines if extrapyramidal symptoms develop: Immediate discontinuation is mandatory 1